Short-term Observation on the Clinical Application Effect of Astra Tech Implant EV Short Implants for Maxillary Sinus Elevation

December 8, 2025 updated by: Linhu Wang
Short-term comparison of clinical application effects of Astra OsseoSpeed EV short implants and conventional implants for maxillary sinus elevation

Study Overview

Detailed Description

  1. If the survival rate, marginal bone resorption , complications and patient satisfaction of the short implant group are comparable or better than those of the conventional implant group, then short implants can be regarded as an effective treatment option for insufficient alveolar bone in the posterior teeth area. Thus, in clinical practice, the investigators can utilize short implants combined with transcrestal sinus floor elevation, or even implant short implants to help patients with certain insufficient maxillary bone complete implant restoration without resorting to more complex, costly and more invasive external elevation surgery to increase the length of posterior teeth implants in the maxillary region.
  2. If it is found that the short implant group has a higher incidence of complications or a lower long-term survival rate, further exploration of its indications and optimization of surgical strategies is required.

Study Type

Interventional

Enrollment (Estimated)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: lin hu Wang, Doctoral
  • Phone Number: +8618086060633
  • Email: 316036445@qq.com

Study Locations

    • Hubei
      • Wuhan, Hubei, China, 422202
        • No. 26, Shengli Street, Jiang'an District, Wuhan City, Hubei Province, China
        • Contact:
          • lin hu Wang, Doctor's degree
          • Phone Number: +8618086060633
          • Email: 316036445@qq.com

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Patients aged over 18 years old with at least one area of the posterior dental arch having insufficient alveolar bone height (3-6 mm)
  • Patients are in good health and have no major systemic diseases such as diabetes or cardiovascular diseases, and no maxillary sinus lesions
  • They are willing to undergo implant restoration treatment and can complete at least 3-year follow-up.

Exclusion Criteria:

  • horizontal bone deficiency alveolar ridges,bone defects caused by tumor resection
  • excessive tobacco use (more than 10 cigarettes per day)
  • severe liver and kidney diseases
  • history of radiotherapy and chemotherapy in the head and neck region
  • uncontrolled diabetes
  • active periodontal disease
  • oral mucosal diseases in the treatment area or poor oral hygiene,
  • PI > 70%

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Sequential Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: transcrestal sinus floor elevation
Short-term clinical outcome of Astra OsseoSpeed EV short implants (L=6.3mm) for transcrestal sinus floor elevation
Short-term clinical outcome of Astra OsseoSpeed EV short implants (L=8mm) for transcrestal sinus floor elevation
conventional implants (L=9mm) in the posterior maxillary region for dental restoration

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Various complications
Time Frame: From having a tooth implant to one year after wearing the dentures
the rate of Implant survival, swelling, pain, etc.
From having a tooth implant to one year after wearing the dentures

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
marginal bone resorption
Time Frame: one year
Measure the changes in the bone height around the implant
one year

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient satisfaction
Time Frame: From having a tooth implant to one year after wearing the dentures
Very satisfied, satisfied, dissatisfied, the rate of dissatisfaction, etc.
From having a tooth implant to one year after wearing the dentures

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 10, 2025

Primary Completion (Estimated)

June 30, 2027

Study Completion (Estimated)

July 30, 2028

Study Registration Dates

First Submitted

November 22, 2025

First Submitted That Met QC Criteria

December 6, 2025

First Posted (Estimated)

December 9, 2025

Study Record Updates

Last Update Posted (Actual)

December 16, 2025

Last Update Submitted That Met QC Criteria

December 8, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Methods and Results

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe